If we redesign surgical implants, can we improve the outcomes of surgical procedures?
We are transforming surgical implants and tools through an AI-driven 3D design platform aimed at maximizing patient outcomes. Our initial focus is to serve the significant unmet need for innovation in devices that treat stress urinary incontinence, starting with surgical mesh implants.
For more than five years, Smartweave has collaborated with leading surgeons, researchers, and domain experts to bring AI-driven 3D design for surgical tools and devices to the operating room through learning and innovation.
That foundation has yielded a suite of high value solutions – including the “Kasim” AI-based platform for 3D design and printing of personalized surgical implants.
Our breakthrough is to integrate virtual human twins in the design of biomaterial and biomechanical innovations that can be optimized through AI for particular patients. Implants and tools designed through Kasim would not only prevent complications common to surgical interventions, including scarring, bleeding and tissue damage, they would also be tightly coupled with training simulations that can accelerate onboarding physicians to new surgical protocols. We expect our innovations will change the trajectory of how surgical implants deliver value for patients in sub-specialities ranging from urinary, cardiac, orthopedic and even neural implants.
The 3DEXPERIENCE platform empowers Smartweave to design, simulate and optimize 3D shapes and structures, so to better iterate on and manage product revisions. This platform also enables Smartweave to aggregate Business Intelligence data for powerful analysis from which it can draw actionable insights and perform predictive analytics on innovation in the virtual human modelling environment.
Although surgical implants represent a multibillion-dollar market, innovation has been mired in incremental improvements to implant design. As a result, devices for treating such conditions as stress urinary incontinence have experienced failure rates up to 25% and complication rates up to 20%.
Smartweave’s breakthroughs in personalized implants can deliver the impact that patients and surgeons around the world urgently demand. We are structuring alliances with leading strategic partners such as Dassault (for 3D solutions), Cellink (for 3D bioprinting) and the Texas Medical Center (for induction into their network of teaching hospitals in our innovations) to help co-develop and commercialize our innovations.
Do you think your project is the next big thing?
Join the team !